Implementation of an Oral Chemotherapy Adherence Intervention

NARecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

May 28, 2025

Primary Completion Date

August 30, 2028

Study Completion Date

August 30, 2028

Conditions
Solid TumorHematologic Malignancy
Interventions
BEHAVIORAL

Multilevel Adherence Intervention

Participants enrolled in this adherence program will have individualized counseling sessions with their clinical pharmacists regarding their oral anticancer agent based on their risk-stratified monitoring category. Participants will be followed longitudinally and will receive tailored support.

Trial Locations (1)

27516

RECRUITING

UNC Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

UNC Lineberger Comprehensive Cancer Center

OTHER

NCT06989489 - Implementation of an Oral Chemotherapy Adherence Intervention | Biotech Hunter | Biotech Hunter